The industry is categorized into seasonal, perennial, and occupational rhinitis. Among these, the Allergic Rhinitis Market segment for seasonal allergies remains the largest, driven by the massive annual influx of pollen-related cases. However, the occupational segment—triggered by workplace dust, chemicals, and fumes—is gaining attention as industrial safety standards become more stringent globally. Employers are now partnering with health providers to offer on-site allergy screening and management tools.

From a product perspective, the market is split between over-the-counter (OTC) and prescription medications. While OTC products dominate the volume due to their accessibility in retail pharmacies, the prescription segment maintains high value through the introduction of biologics. These advanced therapies, which target the underlying IgE-mediated response, are contributing significantly to the overall Allergic Rhinitis Market Size, offering hope to patients who have failed traditional therapies.

Related Reports